Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
PHASE4
The purposes of this study are to assess the efficacy, safety, and side eff...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician
Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer
PHASE2
This is a longitudinal, one arm, prospective phase II study, designed to ev...
Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach
PHASE2
The objective of this study is to respond to frequent requests from patient...
Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study
PHASE3
This is a multicenter, randomized, controlled, double-blind, phase III stud...
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
PHASE3
The purpose of this study is to assess the efficacy and safety of olanzapin...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.